Monthly Archives: July 2020
Recurrent urinary tract infections are a common, bothersome problem, particularly in female patients. As a result, providers will often try to stave off future infections by prescribing prophylactic antibiotics. Patients can often end up taking these antibiotics for months or even years, either for continued UTI prophylaxis or because their pharmacist or physician does not […]
Read More
Glucagon-like peptide-1 receptor agonists, or GLP-1s, are a highly appealing, newer class of medications for the treatment of type 2 diabetes. Through their activity at the GLP-1 receptor, they slow gastric emptying and decrease glucagon secretion. They also increase the body’s endogenous insulin production, but they do not have as high of a risk for […]
Read MoreI love to try to give back to the subscribers that continue to support the podcast and my mission to educate healthcare professionals about pharmacology. Today is a special day and I’m finally releasing the paperback version of my latest work that has taken over a year to develop! I’m giving it away for a cheap as […]
Read More
Osteoporosis is the condition in which bone density is reduced and the patient has an increased risk of fractures. According to the International Osteoporosis Foundation, an estimated 44 million people in the US population aged 50 and older suffer from osteoporosis and low bone mass. There are many risk factors such as age, alteration of […]
Read More
I’ve encountered numerous patients who are taking chronic, oral corticosteroids. We know that there are numerous potential adverse effects from long term corticosteroid use. Osteoporosis, cardiovascular risks, diabetes, and cataracts are a few of the potential complications from chronic use. Listen to more potential complications and adverse effects from corticosteroids here. Tapering corticosteroids can be […]
Read More